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Abstract
Background: Carcinoma of the gallbladder (GBC) clinically mimics benign gallbladder diseases and often escapes
detection until advanced stage. Despite the frequency of cholecystectomy, diagnosis of GBC remains problematic
in many situations. We sought to identify pathologic features that contribute to the difficulty in recognition of GBC.
Methods: We identified 23 patients (ranged from 45 to 86 years, male to female ratio 1:4.5) with carcinoma
involving the gallbladder referred to an academic medical center over a period of 10 years for study. This includes
10 cases of primary GBC, 6 cases of metastatic tumor to gallbladder, 6 cases of directly invasive adenocarcinoma
arising elsewhere in the biliary tree, and one case of unidentified origin adenocarcinoma. Primary tumors include
adenocarcinoma not otherwise specified (NOS) in 6 cases, papillary adenocarcinoma in 2 cases, and single cases of
undifferentiated carcinoma and combined adenocarcinoma and neuroendocrine carcinoma (NEC). Metastatic
tumors to gallbladder were from a wide range of primary sites, predominantly the gastrointestinal tract.
Results: These cases illustrate seven potential pitfalls which can be encountered. These include: 1) mistakenly
making a diagnosis of adenocarcinoma of gallbladder when only benign lesions such as deeply penetrating
Rokitansky-Aschoff sinuses are present (overdiagnosis), 2) misdiagnosing well-differentiated invasive carcinoma with
minimal disease as benign disease (underdiagnosis), 3) differentiating between primary NEC of gallbladder and
metastasis, 4) confusing primary mucinous adenocarcinoma of gallbladder with pseudomyxoma peritonei from a
low grade appendiceal neoplasm disseminated to gallbladder, 5) confusing gangrenous necrosis related to
cholecystitis with geographic tumoral necrosis, 6) undersampling early, grossly occult disease, and 7)
misinterpreting extracellular mucin pools.
Conclusions: Clinical history and a high index of suspicion are prerequisite to detecting GBC. Detection of GBC at
an early stage is difficult because the symptoms mimic benign gallbladder diseases. Misinterpretation of subtle
microscopic abnormalities contributes diagnostic failures in early cases. Careful attention to any evidence of mural
thickening, thorough sampling, particularly in older patients, and close examination of any deeply situated
glandular structures are critical. Correlations with radiographic and clinical findings are important helps to avoid
misdiagnosis in this commonly resected organ.
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Gallbladder carcinoma (GBC) is a relatively uncommon
neoplasm that shows female predominance (female to
male ratio, 3-4: 1), possibly related to the increased inci-
dence of calculi in women. The mean age of patients is
65 years, compared to a mean age of presentation with
cholelithiasis of 49 years. In the United States, Hispanic
and Native Americans have a higher rate of gallbladder
cancer than other ethnic groups. Gallbladder carcinomas
are associated with gallstones (80%), porcelain gallblad-
der (10-20%), and abnormal choledochopancreatic duct
junction. Size of the gallstones may also be a risk factor,
as patients with stones larger than 3 cm have a signifi-
cantly greater risk of developing carcinoma. Recently,
clinical and epidemiological studies have suggested a
link between gallstone disease [1], GBC as well as other
hepatobiliary diseases and previous infection with Heli-
cobacter species [2]. Sixty percent of GBC arise in the
fundus. Invasion of liver, lymph nodes and other organs
are frequent. Histologically, most GBC are pancreatobili-
ary-type adenocarcinomas, showing variable degrees of
differentiation. Some arise in association with a noninva-
sive papillary neoplasm. Additional, several histologic
variants of adenocarcinoma are recognized: papillary,
intestinal, mucinous, signet-ring cell and clear cell.
Many tumors contain more than one histologic variant.
The remaining epithelial cell types occurring in the gall-
bladder include adenosquamous carcinoma, squamous
cell carcinoma, small cell carcinoma, and undifferen-
tiated carcinoma. The determination of the histological
type of the tumor and differential diagnosis from gall-
bladder adenocarcinoma are often difficult [3,4]. Failure
to detect early disease contributes to a generally poor
prognosis. Preliminary observations indicating poten-
tially frequent under- and over-diagnosis of GBC led us
to undertake this study. In the present report, we review
our experience with GBC over a 10 year period, noting
some of the pitfalls which can be encountered. We also
suggest some ways whereby these pitfalls may be
avoided.
Methods
This retrospective study was carried out from data on
23 patients with carcinoma of the gallbladder retrieved
from the surgical pathology files of an academic medical
center between January 2001 and November 2011.
Patients with pathologic materials referred to the Uni-
versity of Oklahoma Medical Center (OUMC) and a
diagnosis of carcinoma involving the gallbladder were
eligible for the study. The surgically resected specimens
were fixed in 10% neutral-buffered formalin and
embedded in paraffin. Sections were used for hematoxy-
lin and eosin staining and immunohistochemical
examinations. Slides from some patients were reviewed
as whole slide digital images if the primary materials
had been returned to a referring institution after the
patient was seen at OUMC.
Results
Of our 23 cases, 18 presented few difficulties in diagno-
sis. The most common presenting symptoms of primary
GBC were abdominal pain predominantly in the epigas-
tric and right upper quadrant, jaundice, nausea, vomit-
ing, anorexia, and weight loss (50%). Imaging studies
performed in all the patients showed the presence of
gallstones in 14 (60%) cases overall, and in 90% of cases
of primary GBC. Grossly evident tumor was seen on
initial pathologic examination in 12 of 23 cases (52%).
Eight (80%) of 10 primary GBC cases had tumor masses,
while 2 cases grossly presented no visible tumor. The
most common tumor sites were in the body and the
neck of gallbladder. Carcinoma was suspected pre-
operatively in only 5 patients (22%), while the clinical
diagnosis in the remainder was acute cholecystitis, stone
disease and bile duct tumor. Surgical specimens from
the 10 patients with primary adenocarcinoma showed
adenocarcinoma NOS in 6 cases, papillary adenocarci-
noma in 2 cases, and single cases of undifferentiated
carcinoma and combined adenocarcinoma and NEC
(See Table 1). In the adenocarcinoma NOS group, 4
cases were moderately differentiated and 2 cases were
well differentiated carcinoma.
Five of our cases presented particular challenges in
diagnosis. These included one patient in whom the diag-
nosis was made only after the initial cholecystectomy
specimen was reviewed four years later when he pre-
sented with bowel obstructive symptoms due to perito-
neal carcinomatosis, one patient in whom surface
dysplasia involving Rokitansky-Aschoff sinuses (RAS)
and adenomyosis was mistaken for deeply invasive carci-
noma, one patient in whom geographic tumoral necrosis
closely resembled acute gangrenous necrosis more typi-
cal in acute cholecystitis, and one patient with isolated
mucin pools and only rare tumor cells. One additional
patient with a combined adenocarcinoma and NEC pre-
sented a challenge in differential diagnosis of primary
vs. metastasis as well (See Table 2).
Discussion
Well-differentiated adenocarcinoma of the gallbladder
can be difficult to distinguish from RAS, which can be
located throughout the gallbladder wall, even extending
into perimuscular adipose tissue. RAS are normally con-
tinuous, showing a perpendicular orientation to the sur-
face, and typically have undulating, smooth contours
(See Figure 1A, B). In contrast, adenocarcinomas show
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[5]. The malignant glands areu s u a l l yd e n s e l yp a c k e d
and may be oriented parallel to the surface. Desmoplasia
favors a diagnosis of carcinoma. However, a stromal
desmoplastic-like reaction surrounding RAS is not
uncommon, especially when there is active cholecystitis.
Moreover, cytologic atypia, mitoses, and intraglandular
necrosis are all features that favor a diagnosis of adeno-
carcinoma over benign RAS [4,6].
Two of our cases (see Table 2, A and E) illustrate the
pitfalls associated with this challenging aspect of gall-
bladder microanatomy. Surface dysplasia was identified
on initial evaluation of case E and subsequently sub-
mitted additional sections demonstrated numerous areas
in which dysplasia extended into deeply situated RAS,
mimicking transmural invasion of carcinoma. However,
some lateral intramural growth was also present without
typical associated mucosal stroma in which atypical
Table 2 Summary of case details in problematic cases:
Case Clinical Presentation Radiology Gross Description Final Diagnosis
A6 6 y o
male
abdominal pain, 4 years post
cholecystectomy for ruptured
cholecystitis and cholelithiasis
CT: peritoneal
carcinomatosis and free
fluid
Peritoneal implants with slight
granular thickening of peritoneum
Gallbladder wall 5 mm thick no
mass, and gallstones in the lumen
Well differentiated adenocarcinoma
of the gallbladder and peritoneal
metastasis
B4 9 y o
female
On routine examination, pelvic
mass and gallbladder polyp were
found with no remarkable clinical
symptoms
CT: an enhancing 2 cm
mass in the GB fundus.
US: heterogeneous
mass with associated
internal flow worrisome
for GB malignancy:
cholelithiasis
Polypoid mass protruding from a
stalk (4.0 × 2.3 × 1.4 cm) gallstones.
On cut section the polyp was white
tan, homogeneous throughout
Combined adenocarcinoma and
neuroendocrine carcinoma, poorly
differentiated
C8 6 y o
female
Three days of RUQ pain, nausea,
fever. History of breast cancer S/P
mastectomy 7 years ago, treated
with Tamoxifen, squamous cell
carcinoma of nose, ovarian cyst
removal
US & CT: gallstones and
sludge; pancreatic head
mass
BG 9.5 × 6.5 × 6.0 cm. seven firm
yellow to black multi-faceted calculi.
GB wall thickened to 1.5 cm.
Mucosa lined by friable pale tan
necrotic tissue extruded into lumen.
3.5 cm maximal tumor size,
circumferential at neck and filling
up to 30% of the luminal volume
Pancreatic biopsy: adenocarcinoma
with abundant lymphocytes. GB:
Undifferentiated carcinoma of GB
with extensive necrosis and acute/
chronic inflammation
D5 3 y o
female
Increasing abdominal girth over
several months
CT & US: moderate
volume ascites, 18.5 cm
complex right pelvic
mass; GB: 1.8 cm polyp
A 5 cm appendix filled with yellow-
tan mucoid material.
Gallbladder was 7.3 × 3 cm in
greatest dimensions with a flesh
colored lesion presenting in the
serosa. The mucosa was
unremarkable
Low grade mucinous neoplasm/
adenocarcinoma of the appendix
with peritoneal spread
E4 5 y o
female
RUQ pain Cholelithiasis Mural thickness 5 mm; no mass;
stones up to 2.5 cm
Focally invasive adenocarcinoma;
extensive CIS involving RAS
Abbreviations: GB = gallbladder; CT = computed tomography scan; US = ultrasound examination; RAS = Rokitansky-Aschoff sinuses; RUQ = right upper quadrant;
CIS = carcinoma in situ; S/P = status-post
Table 1 Clinical and pathologic features of patients with gallbladder malignancies
Feature of primary GB carcinoma N0 (Percentage)
Clinical symptoms
(abdominal pain, jaundice, nausea and vomiting, weight loss)
5/10 (50%)
Mass 8/10 (80%)
Gallstones 9/10 (90%)
Mass associated with gallstones 8/9 (89%)
Pre-op diagnosis benign diseases 5/10 (50%)
Pre-op diagnosis GB cancer 2/10 (20%)
Pre-op diagnosis bile duct tumor 3/10 (30%)
Malignant postoperative diagnosis Primary: 10/23 (43%)
Metastasis to GB: 6/23 (26%)
Bile duct carcinoma invasive into GB: 6/23 (26%)
Unidentified origin carcinoma: 1/23 (5%)
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In contrast, another case in our series (case A) demon-
strated small glands embedded in bundles of smooth
muscle and surrounding a deep vessel, but resembling
RAS (See Figure 1C, D). The surface mucosa was
inflamed and also associated with some atypia, making
it difficult to differentiate from reactive atypia involving
the surface and RAS. However, the lining cells of deep
glands presented cytological and subtle architectural aty-
pia without significant inflammation. The surface
epithelium exhibited multiple areas with high grade dys-
plasia (See Figure 1D, E). Further, the stroma
surrounding the deeply situated glands was more des-
moplastic than inflammatory in nature. The morpholo-
gical diagnosis at the time was cholecystitis.
Unfortunately, 4 years post-cholecystectomy, the patient
presented with abdominal pain and radiographic evi-
dence of disseminated peritoneal implants. Surgical sam-
pling at this point led to a diagnosis of metastatic well
differentiated adenocarcinoma. Immunostains showed
t h et u m o rc e l l st ob ed i f f u s e l yp o s i t i v ef o rC K 7a n d
negative for CK20, WT1, D240, calretinin, CK5/6 and
TTF1. MUC-1, MUC-5A, MLUC6, P53 were positive in
the tumor cells. Subsequent review of the previously
Figure 1 Benign mimicking malignant, and malignant mimicking benign in the gallbladder. A-B: RAS extending transmurally, without any
associated dysplasia, C: Glands embedded in bundles of smooth muscle resembling RAS, D: Well-differentiated glandular structures embedded
deeply in the gallbladder wall with subtle atypia, E: Foci of back to back arrangement of glands lined by layers of highly atypical columnar cell.
Many mitoses presented, F: Diffuse wall thickening with intramural diverticula within the wall, mimicking well-differentiated adenocarcinoma of
the gallbladder (H&E stain).
Giang et al. Diagnostic Pathology 2012, 7:10
http://www.diagnosticpathology.org/content/7/1/10
Page 4 of 8removed gallbladder revealed the small primary tumor
and associated surface dysplasia.
Adenomyosis can also be confused with adenocarci-
noma of gallbladder. It is a hyperplastic condition char-
acterized by excessive proliferation of surface epithelium
with deepened invaginations or diverticula extending
into the thickened muscular layer of gallbladder wall,
again mimicking well-differentiated adenocarcinoma of
the gallbladder. However, the glands in adenomyosis are
usually bland cytologically; they show cystic dilatation,
and they communicate with the main gallbladder lumen
[7,8] (See Figure 1F). Pathologists should be aware of
the presence of glandular structures embedded in the
gallbladder wall. This condition does not simply suggest
RAS or adenomyosis. The precise evaluation of the
appearance of the whole lesion may be useful in distin-
guishing these diseases.
The immunoprofile of GBC is similar to that of bile
duct carcinoma (intrahepatic and extrahepatic) and pan-
creatic carcinoma. Cytokeratin 7 (CK7) is almost always
positive, Cytokeratin 20 (CK20) can be positive, more
often in extrahepatic bile duct carcinoma than
intrahepatic cholangiocarcinoma. In addition, carcinoem-
bryonic antigen-monoclonal (CEA-M), carbohydrate
antigen (CA19-9), B72.3, MUC1, and MUC5AC are also
positively expressed in bile ducts and GBC but can be
focal. MUC overexpression rates are reportedly higher in
GBC than in cholecystitis and gallbladder adenoma [7,8].
Another potential problem area that should be consid-
ered is carcinoma arising from RAS, without tumor mass
[3]. We believe this is extremely rare, although conceiva-
bly more advanced cancers could have arisen from such a
location. Demonstration of this requires a minute adeno-
carcinoma arising from RAS and located in the wall or
subserosa, with no apparent connection to mucosa as in
case E above (See Table 2) of a 45-year-old woman with
preoperative diagnosis of cholelithiasis. The morphologi-
cal diagnosis at another hospital was transmurally inva-
sive moderately differentiated adenocarcinoma, though
no mass was identifiable grossly and the wall only focally
thickened to 5 mm. Subsequent review of the previously
removed gallbladder revealed extensive surface dysplasia,
with high grade dysplastic epithelium within RAS pene-
trating slightly beyond the wall (See Figure 2A) and foci
Figure 2 Dysplasia in RAS and adenomyosis can mimic invasive GBC. A-B: Dysplastic epithelium within RAS penetrating slightly beyond the
wall, C: dysplastic epithelium associated with adenomyosis, D: Foci of intramural invasive carcinoma (H&E stain).
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gradual transition between adenocarcinoma cells and
RAS with dysplasia was recognized. A key differentiating
feature from adenomyosis is that muscular hypertrophy
was not pronounced. Cytologic atypia sufficient for a
diagnosis of adenocarcinoma should also be evident. In
general, carcinoma arising from RAS is small and has a
relatively good prognosis. Therefore, careful examination
of resected gallbladders is necessary [6], particularly any
areas of focal mural thickening.
Some important pathologic findings overlap in benign
and malignant lesions and may contribute to possible
confusion, such as necrosis or extracellular mucus. An
acute cholecystitis with parietal necrosis can be confused
with an aggressive neoplastic process. Similarly, exten-
sive tumor necrosis with minimal residual viable tumor
may mimic acute gangrenous cholecystitis. Almost all
cellular detail is lost in necrosis and most immunoper-
oxidase stains either fail or give misleading, non-specific
falsly positive results. The presence of associated clinical
signs can be of value to make the diagnosis of carci-
noma or acute cholecystitis. The characteristics of the
histologic changes in acute cholecystitis such as edema,
vascular congestion, hemorrhage, fibrin deposition in
the adventitia and adjacent muscle should be noted.
Mucosal and mural necrosis may be seen with neutro-
phils [4,9]. Likewise, thorough histologic sampling is cri-
tical in cases with extensive necrosis to reveal diagnostic
viable tumor. Since necrosis can occur in acute chole-
cystitis or a malignant tumor, it is important to ade-
quately sample the gallbladder, including areas without
necrosis. This is illustrated by case C above, a case of an
86-year-old woman with preoperative diagnosis of acute
suppurative cholecystitis with cholelithiasis. She under-
went cholecystectomy. Although gross tumor was pre-
sent, significant geographic necrosis was present with
prominent acute, chronic, and xanthogranulomatous
inflammation, and viable tumor was only present in a
subset of the well-sampled tumor (See Figure 3).
The finding of focal high grade glandular dysplasia or
intramucosal adenocarcinoma within the gallbladder
strongly favoured origin of this carcinoma within the
gallbladder, despite the history of two other malignancies.
IHC stains showed focal moderate tumor immunoreac-
tivity for synaptophysin consistent with focal neuroendo-
crine differentiation. In this case, her find needle biopsy
of the head of the pancreas revealed findings suggestive
of typical adenocarcinoma. Given her history of bilateral
breast cancer and a pancreatic tumor, metastatic tumor
would have been more likely than a primary GBC. Taking
a very careful cancer history and maintaining a high
index of suspicion together with comparing her current
findings with prior histologic appearances and appropri-
ate IHC study was prerequisite to accurate diagnosis.
Necrosis may be present in many diseases. An incorrect
diagnosis could be made if primarily based on necrosis.
Another potentially confusing factor is extracellular
mucin. Mucinous carcinoma of gallbladder is uncom-
mon, representing only 4% of all malignancies. It is
characterized by small clusters of malignant epithelial
cells surrounded by large deposits of extracellular
mucin. In general, there are few epithelial glandular ele-
ments and when present, they are often distended with
mucin [4]. In case D above (See Table 2), radiographic
study suggested the possibility of a primary gallbladder
neoplasm or a gynecologic neoplasm. At exploration,
extensive peritoneal mucinous tumor was present which
was removed as much as possible, along with the appen-
dix, gallbladder, and pelvic mass. The appendix showed
a villiform mucinous epithelial proliferation replacing
the normal appendiceal mucosa. The peritoneal and
gallbladder samples were characterized by abundant
pools of mucin containing scattered single infiltrating
glands and cellular proliferations lined by mucinous
Figure 3 Geographic necrosis can mask underlying GBC. A: Extensive geographic necrosis and prominent acute inflammation (H&E stain,
X100), B: The tumor was characterized by vesicular nuclei, prominent nucleoli, and scant eosinophilic cytoplasm (H&E stain, X400).
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logic atypia (See Figure 4). The mucinous epithelium in
the peritoneal lesions and gallbladder were the same as
in the appendiceal lesion.
A diagnosis of mucinous carcinoma should be sus-
pected from gross examination when large amounts of
mucus are found in the primary tumor. However, it was
easily mistaken for pseudomyxoma peritonei dissemi-
nated to gallbladder. Pseudomyxoma peritonei (PMP) is
an uncommon disease characterized by abundant extra-
cellular mucin in the peritoneum. It is an older, broad
descriptive term embracing a wide spectrum of biologi-
cal behaviour of neoplasms from the benign and border-
line to malignant lesions. PMP is usually associated with
a mucinous neoplasm in the appendix that demonstrates
fairly bland well differentiated mucinous epithelium
often with minimal nuclear features of malignancy and
minimal or no invasion [10,11].
Hence, it can be diagnostically challenging to recog-
nize a primary mucinous tumor of the gallbladder vs.
PMP disseminated to gallbladder, especially in cases in
which only the gallbladder is removed. Similarly, muci-
nous metaplasia in the gallbladder may be associated
with mucosal ulceration, particularly if stones are pre-
sent, presenting the appearance of possible pools of sur-
face or submucosal mucin. This circumstance warrants
close sectioning to avoid missing a primary mucinous
neoplasm of the gallbladder.
Besides pure adenocarcinoma of the gallbladder, many
tumors contain more than one histologic variant. In this
study, one case was diagnosed as a mixed endocrine-
exocrine carcinoma. NET are thought to be derived
from enterochromaffin or Kulchitsky cells, which are
widely distributed in the body. Consequently, NET can
be found in any location in the body, although the sites
most commonly affected are the gastrointestinal and
bronchopulmonary tracts, representing approximately
67% and 25% of cases, respectively. NET of the gallblad-
der is extremely rare because normal gallbladder mucosa
does not contain neuroendocrine cells. Neuroendocrine
cells can be detected at sites of intestinal metaplasia
induced by chronic inflammation, which may be the
initial step in the development of NET. This NET com-
ponent may thus be in the deep mucosa of the gallblad-
der, and potentially produce a more deeply infiltrating
tumor involving the serosa and adjacent liver before or
without any surface component. Therefore, the differen-
tial diagnosis of a primary NEC of the gallbladder and
one arising from metastasis is difficult [12-14]. Our case
showed a tumorous lesion involving the gallbladder wall
accompanied by atypical hyperplastic and dysplastic
epithelium. Although the predominant element in the
tumorous lesion was adenocarcinoma, there were some
foci composed of small cells with neuroendocrine mor-
phology at the microscopic level (See Figure 5).
This patient’s immunohistochemistry staining results
were positive for cytokeratin and synaptophysin. These
findings were suggestive of mixed endocrine-exocrine
carcinoma involving full thickness of the gallbladder
wall. In summary, NET of the gallbladder is extremely
rare. As a single dominant element, metastasis may be
more common than primary origin in the gallbladder.
Conclusion
Carcinoma of the gallbladder is a poor prognosis malig-
nancy since it usually presents at a very advanced stage.
Detection of GBC at an earlier stage is very difficult
because the symptoms most of the time mimic benign
gallbladder diseases like chronic cholecystitis, adeno-
myosis and because the absence of a gross lesion makes
pathologic detection problematic. Further, we have illu-
strated and identified from our experience other patho-
logic factors leading to misdiagnosis. Misinterpretation
of subtle microscopic abnormalities appears to
Figure 4 Extracellular mucin can originate from mucinous metaplasia, GBC or metastasis. A: Expansile pools of mucin with scattered glands,
the mucinous epithelium exhibited cytologic atypia (H&E stain, X100), B: Neoplastic glands within the wall of gallbladder (H&E stain, X100).
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cases. Careful attention to any evidence of mural thick-
ening, thorough sampling, particularly in older patients,
and close examination of any deeply situated glandular
structures that may be mimicking RAS are critical.
Further, correlation with radiographic and clinical find-
ings can also be important helps to avoid misdiagnosis
in this commonly resected organ.
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